ANG Lifesciences India Ltd.

As of June 30, 2026, ANG Lifesciences India Ltd. carries a market capitalization of 504.83M, placing it among publicly traded companies globally. Its enterprise value stands at 504.83M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, ANG Lifesciences India Ltd. has 13.06M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 504.83M versus a market cap of 504.83M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.11M in revenue per employee across its workforce of 395.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, ANG Lifesciences India Ltd. recorded an income tax benefit of -25.36M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -158.59M and -133.23M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, ANG Lifesciences India Ltd.'s stock has gained approximately 2.17% over the past 52 weeks. The 50-day moving average sits at 34.44, while the 200-day moving average is 29.66.

Over the twelve months ended June 30, 2026, ANG Lifesciences India Ltd. generated 835.87M in revenue and converted that into -133.23M in net income, yielding earnings per share of -10.20. EBITDA reached -18.92M, while operating income came in at -81.90M.

Over the twelve months ended June 30, 2026, ANG Lifesciences India Ltd. posted a gross margin of 34.51, reflecting its pricing power and cost economics. The operating margin of -9.80 and net profit margin of -15.94 provide insight into operational efficiency.

ANG Lifesciences India Ltd.'s most recent stock split took place on July 13, 2022 with a 4:5 split ratio.